CPOUF yields 6.81% · MRK yields 2.76%● Live data
📍 CPOUF pulled ahead of the other in Year 1
Combined, CPOUF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CPOUF + MRK for your $10,000?
Charoen Pokphand Foods Public Company Limited, together with its subsidiaries, engages in the agro-industrial and integrated food businesses in Thailand and internationally. It operates in two segments, Livestock Business and Aquaculture Business. The company produces and sells swine, chicken, cattle, duck, shrimp, and fish feeds; and breeds and farms swine, broiler, layer, duck, and shrimp. It is also involved in the animal feed raw materials distribution, investment and international trading, food products wholesale and retail, property investment, property lease-out, shrimp hatchery, and animal feedmill businesses. In addition, the company produces and distributes elite seeds, pet food, chlortetracycline, aquatic feed, sea food products, as well as motorcycle carburetor, auto parts, and plastic; and imports and distributes eggs, processed meat, milk products, and ready meals. Further, it offers economic and trade consulting, management and advisory, financial guarantee, biological waste management, information technology, food research and development, logistics, and financial services. Additionally, the company engages in the operation of food processing plants, hotels and restaurants, slaughterhouses, and training centers; broiler chicken integration business; provision and development of Asian food products; and swine farm construction activities. It provides its products primarily under the CP and Butcher brands. The company also exports its products. Charoen Pokphand Foods Public Company Limited was incorporated in 1978 and is headquartered in Bangkok, Thailand.
Full CPOUF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.